Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Sportès

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|August 24, 2007
Interleukin-7 immunotherapyClaude Sportès, Ronald E Gress
Annals of the New York Academy of Sciences|January 16, 2010
Perspective on potential clinical applications of recombinant human interleukin-7Claude Sportès, Ronald E Gress, Crystal L Mackall
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 7, 2018
Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patientsPam M Ku, Jennifer L Waller, Claude Sportès, et al.
Journal of Immunological Methods|October 12, 2011
Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral bloodSarfraz A Memon, Claude Sportès, Francis A Flomerfelt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cellsSteven A Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2009
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapyClaude Sportès, Seth M Steinberg, David J Liewehr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patientsClaude Sportès, Nicole J McCarthy, Frances Hakim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancyClaude Sportès, Rebecca R Babb, Michael C Krumlauf, et al.
The Journal of Experimental Medicine|June 25, 2008
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsetsClaude Sportès, Frances T Hakim, Sarfraz A Memon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancerNancy M Hardy, Miriam E Mossoba, Seth M Steinberg, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|August 24, 2007
Interleukin-7 immunotherapyClaude Sportès, Ronald E Gress
Annals of the New York Academy of Sciences|January 16, 2010
Perspective on potential clinical applications of recombinant human interleukin-7Claude Sportès, Ronald E Gress, Crystal L Mackall
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 7, 2018
Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patientsPam M Ku, Jennifer L Waller, Claude Sportès, et al.
Journal of Immunological Methods|October 12, 2011
Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral bloodSarfraz A Memon, Claude Sportès, Francis A Flomerfelt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cellsSteven A Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2009
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapyClaude Sportès, Seth M Steinberg, David J Liewehr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patientsClaude Sportès, Nicole J McCarthy, Frances Hakim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancyClaude Sportès, Rebecca R Babb, Michael C Krumlauf, et al.
The Journal of Experimental Medicine|June 25, 2008
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsetsClaude Sportès, Frances T Hakim, Sarfraz A Memon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancerNancy M Hardy, Miriam E Mossoba, Seth M Steinberg, et al.
Pageof 1